I’ll go on record right now with the prediction that Tecarfarin will not sell more than $25M in any year.
Suffice to say, your prediction looks safe now. Notwithstanding, the company is still apparently going to try and partner the compound so maybe you're not out of the woods yet. lol I hope this is not a case of Zebra's law as I actually do think the rest of their pipeline, in particular the AF compound, has legitimate potential.
Market Data 
Markets 
AI
